[1]郑永征,谢茂松,刘光辉,等.阿那白滞素在治疗大鼠前节内眼模拟手术诱发的血-视网膜屏障破坏中的作用[J].眼科新进展,2020,40(1):016-19.[doi:10.13389/j.cnki.rao.2020.0004]
 ZHENG Yongzheng,XIE Maosong,LIU Guanghui,et al.Role of Anakinra in alleviating blood retina barrier breakdown induced by anterior intraocular simulation operation in rats[J].Recent Advances in Ophthalmology,2020,40(1):016-19.[doi:10.13389/j.cnki.rao.2020.0004]
点击复制

阿那白滞素在治疗大鼠前节内眼模拟手术诱发的血-视网膜屏障破坏中的作用/HTML
分享到:

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
40卷
期数:
2020年1期
页码:
016-19
栏目:
实验研究
出版日期:
2020-01-05

文章信息/Info

Title:
Role of Anakinra in alleviating blood retina barrier breakdown induced by anterior intraocular simulation operation in rats
文章编号:
20200104
作者:
郑永征谢茂松刘光辉潘铭东
350004 福建省福州市,福建中医药大学附属人民医院眼科(郑永征,刘光辉,潘铭东);350004 福建省福州市,福建医科大学附属第一医院眼科(谢茂松)
Author(s):
ZHENG Yongzheng1XIE Maosong2LIU Guanghui1PAN Mingdong1
1.Department of Ophthalmology,Affiliated People’s Hospital of Fujian University of Traditional Chinese Medicine,Fuzhou 350004,Fujian Province,China
2.Department of Ophthalmology,the First Affiliated Hospital of Fujian Medical University,Fuzhou 350004,Fujian Province,China
关键词:
阿那白滞素白细胞介素1β血-视网膜屏障眼前节手术炎症
Keywords:
Anakinrainterleukin-1βblood retina barrieranterior segmentoperationinflammation
分类号:
R779.6
DOI:
10.13389/j.cnki.rao.2020.0004
文献标志码:
A
摘要:
目的 探讨阿那白滞素在治疗前节内眼模拟手术诱发的血-视网膜屏障(blood-retinal barrier,BRB)破坏中的疗效。方法 将大鼠随机分为对照组、模型组、局部治疗组和全身治疗组,每组36只。造模后4 h、1 d、2 d、3 d、5 d和7 d,采用ELISA法检测房水和玻璃体内白细胞介素-1β(interleukin-1β,IL-1β)的浓度。采用Evans蓝作为示踪检测BRB的完整性。结果 造模后1 d、2 d、3 d、5 d四组间房水和玻璃体内IL-1β浓度差异均有统计学意义(均P<0.001)。与对照组相比,模型组、局部治疗组和全身治疗组房水和玻璃体内IL-1β浓度在造模后4 h略有增加(均为P>0.05),造模后1 d显著增加(均为 P<0.05),造模后2 d达到峰值(均为P<0.05),造模后3 d、5 d均下降(均为P<0.05),造模后7 d接近对照组水平(均为P>0.05)。局部治疗组和全身治疗组房水和玻璃体内IL-1β浓度在造模后1 d、2 d、3 d、5 d均低于模型组(均为P<0.05)。局部治疗组房水和玻璃体内IL-1β浓度在造模后1 d、2 d均低于全身治疗组,但造模后3 d高于全身治疗组(均为P<0.05)。造模后1 d、2 d、3 d、5 d四组间视网膜Evans蓝渗漏量差异均具有统计学意义(均为P<0.001)。视网膜Evans蓝渗漏量在造模后1 d局部治疗组低于全身治疗组(均为P<0.05),但在造模后2 d和3 d局部治疗组均高于全身治疗组(均为P<0.05)。局部治疗组和全身治疗组视网膜Evans蓝渗漏量在造模后1 d、2 d、3 d、5 d均低于模型组,但均高于对照组(均为P<0.05)。结论 IL-1β在前节内眼模拟手术诱发的BRB破坏中起重要作用,阿那白滞素可以减轻BRB的破坏作用。
Abstract:
Objective To explore the role of interleukin 1β (IL-1β) in blood retina barrier (BRB) breakdown induced by anterior intraocular simulation operation,and the efficacy of Anakinra in the treatment of BRB breakdown induced by anterior intraocular simulation operation.Methods The rats were randomly divided into control group,model group,local treatment group and systemic treatment group,36 rats in each group.ELISA method was used to measure concentrations of IL-1β in aqueous humor and vitreous body 4 h,1 d,2 d,3 d,5 d and 7 d after modeling.Evans blue test was adopted to detect BRB integrity.Results There were statistical differences in IL-1β at aqueous humor and vitreous body among four groups 1 d,2 d,3 d and 5 d after modeling (all P<0.001).Compared with control group,concentrations of IL-1β in aqueous humor and vitreous body slightly increased 4 h after modeling (all P>0.05),obviously increased 1 d after modeling (all P<0.05),peaked 2 d after modeling (all P<0.05),decreased 3 d and 5 d after modeling (all P<0.05),and were close to control levels 7 d after modeling (all P>0.05) for rats in model group,local treatment group and systemic treatment group.Concentrations of IL-1β in aqueous humor and vitreous body for rats in local treatment group and systemic treatment group were lower than those in model group 1 d,2 d,3 d and 5 d after modeling (all P<0.05).Compared with systemic treatment group,concentrations of IL-1β in aqueous humor and vitreous body for rats in local treatment group were lower 1 d and 2 d after modeling,and higher 3 d after modeling (all P<0.05).Statistical differences were found in retinal Evans blue leakage among four groups 1 d,2 d,3 d and 5 d after modeling,respectively (all P<0.001),but no difference was found 4 h and 7 d after modeling (all P>0.05).Compared with systemic treatment group,retinal Evans blue leakage in local treatment group was lower 1d after modeling,and higher 2d and 3d after modeling (all P<0.05).Retinal Evans blue leakage in local treatment group and systemic treatment group were lower than those in model group and higher than those in control group 1 d,2 d,3 d and 5 d after modeling (all P<0.05).Conclusion IL-1β plays an important role in BRB breakdown induced by anterior intraocular simulation operation,and Anakinra can alleviate BRB breakdown.

参考文献/References:

[1] CHU C J,JOHNSTON R L,BUSCOMBE C,SALLAM A B,MOHAMED Q,YANG Y C.Risk factors and incidence of macular edema after cataract surgery:A database study of 81 984 eyes[J].Ophthalmology,2016,123(2):316-323.
[2] CHEN X Y,SONG W J,CAI H Y,ZHAO L.Macular edema after cataract surgery in diabetic eyes evaluated by optical coherence tomography[J].Int J Ophthalmol,2016,9(1):81-85.
[3] GUO S,PATEL S,BAUMRIND B,JOHNSON K,LEVINSOHN D,MARCUS E,et al.Management of pseudophakic cystoid macular edema[J].Surv Ophthalmol,2015,60(2):123-137.
[4] BUI C M,RECCHIA F M,RECCHIA C C,KAMMER J A.Optical coherence tomography findings in ocular decompression retinopathy[J].Ophthalmic Surg Lasers Imaging,2006,37(4):333-335.
[5] OIE Y,NISHIDA K.Triple procedure:cataract extraction,intraocular lens implantation,and corneal graft[J].Curr Opin Ophthalmol,2017,28(1):63-66.
[6] AGANGE N,MOSAED S.Prostaglandin induced cystoid macular edema following routine cataract extraction[J].J Ophthalmol,2010,2010:690707.
[7] RAO S K,CHEUNG N,LAM D S.Prophylaxis for pseudophakic cystoid macular oedema:a long way to go[J].Clin Exp Ophthalmol,2006,34(4):295-296.
[8] LIM B X,LIM C H,LIM D K,EVANS J R,BUNCE C,WORMALD R.Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery[J].Cochrane Database Syst Rev,2016,11:CD006683.
[9] MIYAKE K,IBARAKI N.Prostaglandins and cystoid macular edema[J].Surv Ophthalmol,2002,47 (Suppl 1):S203-218.
[10] XIE M S,XU G X,HUANG Y.Rat model for anterior segment intraocular surgery induced blood-retinal barrier breakdown[J].Ophthalmologica,2008,222(1):42-47.
[11] XIE M,HUANG L,XU G.Prostaglandin antagonist relieves blood-retinal barrier breakdown induced by anterior segment intraocular surgery in a rat model[J].Arq Bras Oftalmol,2018,81(3):188-194.
[12] GOMES F I,ARAGO M G,BARBOSA F C,BEZERRA M M,de PAULO TEIXEIRA PINTO V,CHAVES H V.Inflammatory cytokines interleukin-1β and tumour necrosis factor-α-novel biomarkers for the detection of periodontal diseases:a literature review[J].J Oral Maxillofac Res,2016,7(2):e2.
[13] SWAMI S K,VIJAY A,NAGARAJAN G,KAUR R,SRIVASTAVA M.Molecular characterization of pro-inflammatory cytokines interleukin-1β and interleukin-8 in asian elephant (Elephas maximus)[J].Anim Biotechnol,2016,27(1):66-76.
[14] DONG N,XU B,WANG B,CHU L,TANG X.Aqueous cytokines as predictors of macular edema in patients with diabetes following uncomplicated phacoemulsification cataract surgery[J].Biomed Res Int,2015,2015:126984.
[15] CHU L,WANG B,XU B,DONG N.Aqueous cytokines as predictors of macular edema in non-diabetic patients following uncomplicated phacoemulsification cataract surgery[J].Mol Vis,2013,19:2418-2425.
[16] GL A,TUGAL-TUTKUN I,DINARELLO C A,REZNIKOV L,ESEN B A,MIRZA A,et al.Interleukin-1β regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of behcet’s disease:an open-label pilot study[J].Ann Rheum Dis,2012,71(4):563-566.
[17] ZHAO M,BAI Y,XIE W,SHI X,LI F,YANG F,et al.Interleukin-1β level is increased in vitreous of patients with neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV)[J].PLoS One,2015,10(5):e0125150.
[18] ABU EAM,ALAM K,NAWAZ M I,MOHAMMAD G,Van DEN EYNDE K,SIDDIQUEI M M,et al.Upregulation of thrombin/matrix metalloproteinase-1/protease-activated receptor-1 chain in proliferative diabetic retinopathy[J].Curr Eye Res,2016,41(12):1590-1600.
[19] CABRAL V P,ANDRADE C A,PASSOS S R,MARTINS M F,HKERBERG Y H.Severe infection in patients with rheumatoid arthritis taking anakinra,rituximab,or abatacept:a systematic review of observational studies[J].Rev Bras Reumatol Engl Ed,2016,56(6):543-550.
[20] SCOTT I C,IBRAHIM F,SIMPSON G,KOWALCZYK A,WHITE-ALAO B,HASSELL A,et al.A randomised trial evaluating anakinra in early active rheumatoid arthritis[J].Clin Exp Rheumatol,2016,34(1):88-93.
[21] OLSON J L,COURTNEY R J,ROUHANI B,MANDAVA N,DINARELLO C A.Intravitreal anakinra inhibits choroidal neovascular membrane growth in a rat model[J].Ocul Immunol Inflamm,2009,17(3):195-200.
[22] LIU D,LON H K,DUBOIS D C,ALMON R R,JUSKO W J.Population pharmacokinetic-pharmacodynamic-disease progression model for effects of anakinra in lewis rats with collagen-induced arthritis[J].J Pharmacokinet Pharmacodyn,2011,38(6):769-786.
[23] XU Q,QAUM T,ADAMIS A P.Sensitive blood-retinal barrier breakdown ouantitation using evans blue[J].Invest Ophthalmol Vis Sci,2001,42(3):789-794.
[24] LIAO S,ZHOU K,LI D,XIE X,JUN F,WANG J.Schisantherin a suppresses interleukin-1β-induced Inflammation in human chondrocytes via inhibition of NF-κB and MAPKs activation[J].Eur J Pharmacol,2016,780:65-70.
[25] WU L,RAMIREZ S H,ANDREWS A M,LEUNG W,ITOH K,WU J,et al.Neuregulin1-β decreases interleukin-1β-induced RhoA activation,myosin light chain phosphorylation,and endothelial hyperpermeability[J].J Neurochem,2016,136(2):250-257.
[26] NOH J M,SHEN C,KIM S J,KIM M R,KIM S H,KIM J H,et al.Interleukin-1β increases angptl4 (FIAF) expression via the JNK signaling pathway in osteoblastic MC3T3-E1 cells[J].Exp Clin Endocrinol Diabetes,2015,123(8):445-460.
[27] LOU L,LIU Y,ZHOU J,WEI Y,DENG J,DONG B,et al.Chlorogenic acid and luteolin synergistically inhibit the proliferation of interleukin-1β-induced fibroblast-like synoviocytes through regulating the activation of NF-κB and JAK/STAT-signaling pathways[J].Immunopharmacol Immunotoxicol,2015,37(6):499-507.
[28] FABIANI C,VITALE A,EMMI G,LOPALCO G,VANNOZZI L,GUERRIERO S,et al.Interleukin (IL)-1 inhibition with anakinra and canakinumab in behet’s disease-related uveitis:a multicenter retrospective observational study[J].Clin Rheumatol,2017,36(1):191-197.
[29] CAMPRUB D,MITJAVILA F,AROSTEGUI J I,CORBELLA X.Efficacy of anakinra in an adult patient with recurrent pericarditis and cardiac tamponade as initial manifestations of tumor necrosis factor receptor-associated periodic syndrome due to the R92Q TNFRSF1A variant[J].Int J Rheum Dis,2017,20(4):510-514.

备注/Memo

备注/Memo:
国家自然科学基金资助项目(编号:81774369)
更新日期/Last Update: 2020-01-05